The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(4-((1-(tert-butoxycarbonyl)-N-(4-(thiophen-2-yl)thiazol-2-yl)piperidine-4-carboxamido)methyl)phenyl)sulfamic acid ID: ALA5267672
Max Phase: Preclinical
Molecular Formula: C25H30N4O6S3
Molecular Weight: 578.74
Associated Items:
Names and Identifiers Canonical SMILES: CC(C)(C)OC(=O)N1CCC(C(=O)N(Cc2ccc(NS(=O)(=O)O)cc2)c2nc(-c3cccs3)cs2)CC1
Standard InChI: InChI=1S/C25H30N4O6S3/c1-25(2,3)35-24(31)28-12-10-18(11-13-28)22(30)29(23-26-20(16-37-23)21-5-4-14-36-21)15-17-6-8-19(9-7-17)27-38(32,33)34/h4-9,14,16,18,27H,10-13,15H2,1-3H3,(H,32,33,34)
Standard InChI Key: TZCXGHRBDVCSQP-UHFFFAOYSA-N
Molfile:
RDKit 2D
38 41 0 0 0 0 0 0 0 0999 V2000
0.4172 1.8834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3008 1.4773 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0116 1.8962 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7297 1.4900 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7371 0.6651 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4553 0.2590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.1660 0.6779 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.8842 0.2717 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-4.5950 0.6906 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-4.5876 1.5156 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-3.1587 1.5028 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.4405 1.9090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3081 0.6523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4246 2.7084 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-5.4202 0.6906 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.8086 -0.1065 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.1320 1.4707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.4027 0.2333 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
0.2099 -0.5865 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5922 -0.6603 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.9175 0.1026 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0048 -1.3749 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.5922 -2.0897 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-1.1636 -2.7084 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8982 -2.3777 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.8059 -1.5535 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.8467 1.8834 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5614 1.4707 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5614 0.6455 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1.8467 0.2328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.1320 0.6455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2761 0.2328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9908 0.6455 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
4.7055 0.2328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4202 0.6455 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.7055 -0.5924 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.4202 -0.1798 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2761 -0.5924 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 2 0
7 6 1 0
7 8 1 0
9 8 1 0
9 10 1 0
7 11 2 0
11 12 1 0
12 4 2 0
13 2 1 0
1 14 2 0
9 15 2 0
9 16 2 0
1 17 1 0
18 13 1 0
18 19 1 0
19 20 2 0
21 20 1 0
13 21 2 0
20 22 1 0
23 22 1 0
23 24 1 0
24 25 2 0
26 25 1 0
22 26 2 0
27 17 1 0
28 27 1 0
29 28 1 0
30 29 1 0
31 30 1 0
17 31 1 0
29 32 1 0
32 33 1 0
33 34 1 0
34 35 1 0
34 36 1 0
34 37 1 0
32 38 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 578.74Molecular Weight (Monoisotopic): 578.1327AlogP: 5.27#Rotatable Bonds: 7Polar Surface Area: 129.14Molecular Species: ACIDHBA: 8HBD: 2#RO5 Violations: 2HBA (Lipinski): 10HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: -1.86CX Basic pKa: ┄CX LogP: 2.29CX LogD: 1.46Aromatic Rings: 3Heavy Atoms: 38QED Weighted: 0.37Np Likeness Score: -1.90
References 1. Zhang W, Wei Z, Huang G, Xie F, Zheng Z, Li S.. (2020) Study of triaryl-based sulfamic acid derivatives as HPTPβ inhibitors., 28 (23.0): [PMID:32992253 ] [10.1016/j.bmc.2020.115777 ]